Health

Uganda study backs shorter TB treatment for children

“Our experience of implementing the four-month TB treatment regimen for children shows that it can be successfully introduced into routine care, leaving no reason to delay its wider roll-out,” Namulwana said.

Under the recommended treatment, children receive a combination of medicines for the first two months, followed by two additional months of treatment using two medicines. (File photo)
By: John Musenze, Journalist @New Vision

 ________________ 

Children in Uganda suffering from non-severe tuberculosis could spend two fewer months on medication following new research showing that a shorter treatment regimen can be successfully implemented in routine health facilities.

A study conducted by Médecins Sans Frontières (MSF) and its research arm, Epicentre in Uganda and the Philippines found that 95% of children enrolled successfully completed treatment, supporting the use of a four-month regimen instead of the standard six months.

The findings, released  November 17th at the Union World Conference on Lung Health in Rio de Janeiro, Brazil, provide evidence that the shorter treatment can be introduced in ordinary healthcare settings, potentially reducing the cost and inconvenience of repeated hospital visits for children and their caregivers.

The study involved 214 children receiving TB care in the two countries, including 72 in Uganda. Researchers found that 73.8% of all the children were eligible for the four-month treatment at the start of therapy.

However, eligibility differed between the countries, with 50% of the Ugandan children qualifying for the shorter regimen compared with 85.9% in the Philippines.

The researchers said the findings demonstrate that children with non-severe, drug-susceptible TB can benefit from shorter treatment when health workers are equipped to assess the severity of the disease and determine who qualifies.

Non-severe TB refers to a milder form of the disease that has not caused extensive damage to the lungs or spread widely in the body. Drug-susceptible TB is a form of the disease that responds to standard first-line medicines.

Dr Maria Namulwana, the study coordinator at MSF/Epicentre Uganda, said the experience demonstrated that the shorter treatment could be successfully introduced into routine healthcare.

“Our experience of implementing the four-month TB treatment regimen for children shows that it can be successfully introduced into routine care, leaving no reason to delay its wider roll-out,” she said.

She said governments needed to invest in training health workers, strengthening diagnostic services, ensuring access to child-friendly medicines and supporting families throughout treatment.

The shorter regimen is expected to ease the burden on families, particularly those who must repeatedly travel to health facilities to collect medicines and monitor their children’s progress.

Valentina Carnimeo, the principal investigator of the multi-country study, said reducing treatment from six to four months would mean fewer clinic visits, lower expenses for caregivers and less disruption to family life.

The regimen uses the same medicines as the standard six-month treatment, including child-friendly formulations, but reduces the duration children must take them.

Under the recommended treatment, children receive a combination of medicines for the first two months, followed by two additional months of treatment using two medicines.

Carnimeo said the shorter duration also reduces the number of days children are exposed to potential side effects of medication.

Challenges to implementation

Despite the positive findings, researchers identified gaps that could prevent more Ugandan children from benefiting from the shorter treatment.

These include limited access to chest X-ray services, inadequate training of healthcare workers and high staff turnover, which affects the continuity of skills needed to assess and manage children with TB.

The study found that chest X-rays were available for all children assessed in the Philippines but for only 55.6% of the cases in Uganda.

Access to chest X-rays is important because health workers use clinical assessments and imaging, where available, to establish whether a child’s TB is severe enough to require the standard six-month treatment.

The findings come as Uganda has already incorporated the shorter treatment recommendation into its national guidelines.

The Ministry of Health’s 2024 National Clinical Guidelines on the Management of Tuberculosis in Children and Adolescents recommend four months of treatment for children aged three months to 14 years with non-severe TB.

However, infants below three months and children who do not meet the criteria for non-severe TB are required to receive longer treatment.

Uganda’s National Tuberculosis and Leprosy Programme annual report for 2023/2024 recorded 10,704 children aged below 15 years diagnosed with TB, representing 12% of all notified TB patients.

The report said this was below the national target of 15%, with approximately 76% of estimated childhood TB cases notified to the programme.

The Ministry has previously reported challenges in identifying children with TB, partly because symptoms can be difficult to recognise and children may struggle to produce sputum samples for testing.

The updated guidelines incorporated newer diagnostic approaches, including the use of stool samples as an alternative for testing children.

Calls for wider access

MSF is now calling on governments, donors and global health partners to accelerate the implementation of the shorter treatment, arguing that adopting guidelines alone is insufficient without investment in the services required to deliver them.

Dr Ana Paula Cavalheiro, the leader of MSF’s Global TB Platform, said children continued to die from a disease that is preventable and curable.

“Every three minutes, a child dies of TB. We cannot keep leaving children behind when effective medical tools are already within reach, including reducing treatment duration for children with non-severe TB from six months to four months,” she said.

According to the World Health Organisation’s 2026 Global TB Report, half of children under five who developed TB in 2025 were not diagnosed and therefore did not access treatment.

MSF said improving access to shorter treatment must go hand in hand with early diagnosis, prevention and access to appropriate medicines so that children can receive care before the disease progresses.

Help us improve! We're always striving to create great content. Share your thoughts on this article and rate it below.

Tags:
Tuberculosis
Children